Immunoinformatics Approach to Design a Novel Subunit Vaccine Against Visceral Leishmaniasis.

Visceral leishmaniasis (VL) infection is mostly caused by and affects countries worldwide. Despite the need for a safe and effective vaccine against leishmaniasis due to the increased drug resistance, however, no vaccine has yet been licensed for clinical use. This study revolves around the immunoinformatics approach to design a multi-epitope vaccine against VL infection.